Literature DB >> 10472532

Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia.

L Faivre1, D Houssin, J Valayer, J Brouard, M Hadchouel, O Bernard.   

Abstract

Liver transplantation may be indicated in patients with GSD type Ia when dietary treatment fails or when hepatic adenomas develop, because they carry a risk of liver cancer or severe intratumoral haemorrhage. Published reports on the results of liver transplantation in patients with GSD Ia include 10 patients and provide little information on long-term outcome. In particular, it is not known whether liver transplantation prevents renal failure due to focal segmental glomerulosclerosis. We report here on 3 patients with GSD Ia in whom liver transplantation was performed at 15, 17 and 23 years of age because of multiple hepatic adenomas in all 3 patients with a fear of malignant transformation, and of poor metabolic balance and severe growth retardation in the youngest one. Renal function was normal in all patients. During the 6-8 years following transplantation, the quality of life has initially greatly improved, with none of the previous dietary restraints and a spectacular increase in height. However, long-term complications included chronic hepatitis C in one patient, gouty attacks in another and focal segmental glomerulosclerosis with progressive renal insufficiency in the third. These results: (1) confirm that liver transplantation restores a normal metabolic balance in patients with GSD Ia, allows catch-up growth and improves the quality of life; (2) suggest that liver transplantation may be considered in teenagers with unresectable multiple adenomas because of a lack of clear-cut criteria to detect malignant transformation early; and (3) suggest that liver transplantation does not prevent focal segmental glomerulosclerosis associated with GSD Ia.

Entities:  

Mesh:

Year:  1999        PMID: 10472532     DOI: 10.1023/a:1005544117285

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  30 in total

1.  Acute renal failure complicating liver transplantation in twin sisters with glycogen storage disease type Ia.

Authors:  C J Reid; D Hebert
Journal:  Transplant Proc       Date:  1996-12       Impact factor: 1.066

2.  Comparison of dietary therapy and portacaval shunt in the management of a patient with type Ib glycogen storage disease.

Authors:  S M Borowitz; H L Greene; J C Gay; W W Neblett
Journal:  J Pediatr Gastroenterol Nutr       Date:  1987 Jul-Aug       Impact factor: 2.839

3.  Liver adenomas in glycogen storage disease in children. Ultrasound and angiographic study.

Authors:  F Brunelle; S Tammam; M Odievre; P Chaumont
Journal:  Pediatr Radiol       Date:  1984

4.  Metastatic hepatocellular carcinoma to bone in a liver transplant patient. A case report.

Authors:  R M Kay; J J Eckardt; L I Goldstein; R W Busuttil
Journal:  Clin Orthop Relat Res       Date:  1994-06       Impact factor: 4.176

Review 5.  Glycogen storage disease in adults.

Authors:  G M Talente; R A Coleman; C Alter; L Baker; B I Brown; R A Cannon; Y T Chen; J F Crigler; P Ferreira; J C Haworth; G E Herman; R M Issenman; J P Keating; R Linde; T F Roe; B Senior; J I Wolfsdorf
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

6.  Hepatic adenomata in type Ia glycogen storage disease.

Authors:  C I Coire; A H Qizilbash; M F Castelli
Journal:  Arch Pathol Lab Med       Date:  1987-02       Impact factor: 5.534

7.  Hepatic adenomata with type 1 glycogen storage disease.

Authors:  R R Howell; R E Stevenson; Y Ben-Menachem; R L Phyliky; D H Berry
Journal:  JAMA       Date:  1976-09-27       Impact factor: 56.272

8.  Hepatocellular carcinoma in type I glycogen storage disease.

Authors:  J Limmer; W E Fleig; D Leupold; R Bittner; H Ditschuneit; H G Beger
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

9.  Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy.

Authors:  P Parker; I Burr; A Slonim; F K Ghishan; H Greene
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682

Review 10.  Nutrition therapy for hepatic glycogen storage diseases.

Authors:  T Goldberg; A E Slonim
Journal:  J Am Diet Assoc       Date:  1993-12
View more
  16 in total

Review 1.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

2.  Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.

Authors:  Elizabeth Drake Brooks; Dianne Little; Ramamani Arumugam; Baodong Sun; Sarah Curtis; Amanda Demaster; Michael Maranzano; Mark W Jackson; Priya Kishnani; Michael S Freemark; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

3.  Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.

Authors:  Julie Clar; Blandine Gri; Julien Calderaro; Marie-Christine Birling; Yann Hérault; G Peter A Smit; Gilles Mithieux; Fabienne Rajas
Journal:  Kidney Int       Date:  2014-04-09       Impact factor: 10.612

Review 4.  Liver transplantation for non-hepatotoxic inborn errors of metabolism.

Authors:  William R Treem
Journal:  Curr Gastroenterol Rep       Date:  2006-06

Review 5.  Recombinant AAV-directed gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Expert Opin Biol Ther       Date:  2011-04-20       Impact factor: 4.388

Review 6.  Transplantation as disease modifying therapy in adults with inherited metabolic disorders.

Authors:  Sandra Sirrs; Fady Hannah-Shmouni; Stephen Nantel; James Neuberger; Eric M Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-02-01       Impact factor: 4.982

Review 7.  Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.

Authors:  Fabienne Rajas; Julie Clar; Amandine Gautier-Stein; Gilles Mithieux
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

Review 8.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

9.  The natural history of glycogen storage disease type Ib in England: A multisite survey.

Authors:  Rebecca Halligan; Fiona J White; Bernd Schwahn; Karolina M Stepien; Nazreen Kamarus Jaman; Mel McSweeney; Steve Kitchen; Joanna Gribben; Charlotte Dawson; Katherine Lewis; David Cregeen; Helen Mundy; Saikat Santra
Journal:  JIMD Rep       Date:  2021-01-24

Review 10.  Liver transplantation in glycogen storage disease type I.

Authors:  Susanna J B Boers; Gepke Visser; Peter G P A Smit; Sabine A Fuchs
Journal:  Orphanet J Rare Dis       Date:  2014-04-09       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.